ES2139087T3 - Inmunoensayos homogeneos que utilizan glucosa-6-fosfato-deshidrogenasas. - Google Patents

Inmunoensayos homogeneos que utilizan glucosa-6-fosfato-deshidrogenasas.

Info

Publication number
ES2139087T3
ES2139087T3 ES94923147T ES94923147T ES2139087T3 ES 2139087 T3 ES2139087 T3 ES 2139087T3 ES 94923147 T ES94923147 T ES 94923147T ES 94923147 T ES94923147 T ES 94923147T ES 2139087 T3 ES2139087 T3 ES 2139087T3
Authority
ES
Spain
Prior art keywords
enzymes
g6pdh
study
phosphate
cisteina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94923147T
Other languages
English (en)
Inventor
Edward B Jakobovits
Joy L Silen
Mark J Levy
Thomas C Goodman
Martin J Becker
Edwin F Ullman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Danisco US Inc
Original Assignee
Dade Behring Marburg GmbH
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH, Genencor International Inc filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2139087T3 publication Critical patent/ES2139087T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A METODOS PARA INMUNOENSAYOS DE ANALITAS QUE EMPLEAN COMO ROTULOS ENZIMAS DE DEHIDROGENASA DE GLUCOSA-6-FOSFATO MUTANTE (G6PDH). EN PARTICULAR, LA INVENCION SE REFIERE AL USO DE CONJUGADOS DE UNA ANALITA O ANALOGO DE ANALITA Y UN G6PDH DEPENDIENTE DE NAD{SUP,+} QUE DIFIERE DE CUALQUIER G6PDH PRECURSOR MEDIANTE LA SUPRESION, SUSTITUCION O INSERCION, O CUALQUIER COMBINACION DE LOS MISMOS DE AL MENOS UN AMINOACIDO POR SUBUNIDAD. LA INVENCION TAMBIEN IMPLICA LA CONSTRUCCION DE VARIAS MUTACIONES EN ENZIMAS DE DEHIDROGENASA DE GLUCOSA-6-FOSFATO PRECURSORAS (G6PDH). TIPICAMENTE, LAS MUTACIONES IMPLICAN LA SUPRESION O SUSTITUCION DE UNO O MAS RESIDUOS DE LISINA, O LA INTRODUCCION DE UNO O MAS RESIDUOS DE CISTEINA MEDIANTE LA INSERCION DE CISTEINA AL G6PDH PRECURSORA O LA SUSTITUCION DE RESIDUOS DE AMINOACIDOS DE G6PDH PRECURSORA CON CISTEINA. LA PRESENTE INVENCION TAMBIEN SE REFIERE A CONJUGADOS DE LAS ENZIMAS DE ESTUDIO Y A ELEMENTOS DE PAR DE UNION ESPECIFICOS, CONJUNTOS UTILES EN LA REALIZACION DE LOS METODOS DE LA INVENCION, LINEAS CELULARES QUE PRODUCEN LAS ENZIMAS DE ESTUDIO, SECUENCIAS DE ADN QUE CODIFICAN LAS ENZIMAS DE ESTUDIO, Y VECTORES QUE CONTIENEN ADN QUE CODIFICA LAS ENZIMAS DE ESTUDIO Y DISEÑADOS PARA PERMITIR QUE UNA CELULA HUESPED PRODUZCA LAS ENZIMAS DE ESTUDIO.
ES94923147T 1993-04-08 1994-04-07 Inmunoensayos homogeneos que utilizan glucosa-6-fosfato-deshidrogenasas. Expired - Lifetime ES2139087T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/044,857 US6455288B1 (en) 1993-04-08 1993-04-08 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases

Publications (1)

Publication Number Publication Date
ES2139087T3 true ES2139087T3 (es) 2000-02-01

Family

ID=21934701

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94923147T Expired - Lifetime ES2139087T3 (es) 1993-04-08 1994-04-07 Inmunoensayos homogeneos que utilizan glucosa-6-fosfato-deshidrogenasas.

Country Status (8)

Country Link
US (3) US6455288B1 (es)
EP (1) EP0710360B1 (es)
JP (1) JP4223546B2 (es)
AT (1) ATE186598T1 (es)
CA (1) CA2160115A1 (es)
DE (1) DE69421617T2 (es)
ES (1) ES2139087T3 (es)
WO (1) WO1994024559A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115616231A (zh) * 2019-07-04 2023-01-17 北京九强生物技术股份有限公司 酶标记物的制备方法

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741715A (en) * 1995-05-30 1998-04-21 Roche Diagnostic Systems, Inc. Quinidine immunoassay and reagents
EP0983509B1 (en) 1997-05-14 2005-08-17 Biosite Diagnostics Inc. Rapid evaluation of the ratio of biological molecules
US6306616B1 (en) 1998-03-27 2001-10-23 Microgenics Corporation Adsorption type confirmatory assays
RU2153674C2 (ru) * 1998-07-28 2000-07-27 Красноярская государственная медицинская академия Способ прогноза развития послеоперационных осложнений в виде генерализованной гнойной хирургической инфекции
JP2002065283A (ja) * 2000-06-12 2002-03-05 Wako Pure Chem Ind Ltd ハイブリッド酵素およびその用途
US7560239B2 (en) * 2002-06-04 2009-07-14 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for simultaneous detection of multiple analytes
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US7115383B2 (en) * 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
US7037669B2 (en) * 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US7279340B2 (en) * 2004-04-07 2007-10-09 Dade Behring Inc. Synthesis and application of procainamide analogs for use in an immunoassay
US20060046273A1 (en) * 2004-08-27 2006-03-02 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for oral fluid
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
US8507280B2 (en) * 2006-08-18 2013-08-13 Ortho-Clinical Diagnostics, Inc. Method of normalizing surface tension of a sample fluid
US8828665B2 (en) 2007-02-16 2014-09-09 Ark Diagnostics, Inc. Compounds and methods for use in detecting gabapentin
US7790401B2 (en) 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
US7910378B2 (en) 2007-12-14 2011-03-22 Siemens Healthcare Diagnostics Inc. Methods for detection of hydrophobic drugs
US20090226900A1 (en) * 2008-03-05 2009-09-10 Helicos Biosciences Corporation Methods for Reducing Contaminants in Nucleic Acid Sequencing by Synthesis
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
WO2010048423A1 (en) 2008-10-24 2010-04-29 Ark Diagnostics, Inc. Levetiracetam immunoassays
SG177613A1 (en) 2009-07-10 2012-03-29 Linzy O Scott Iii Methods and compositions for treating thyroid-related medical conditions with reduced folates
US8329424B2 (en) 2010-06-25 2012-12-11 Siemens Healthcare Diagnostics Reduction in false results in assay measurements
US8771964B2 (en) 2012-02-02 2014-07-08 Siemens Healthcare Diagnostics Inc. Compositions and methods for detection of methadone metabolite
US9658218B2 (en) 2012-05-07 2017-05-23 Siemens Healthcare Diagnostics Inc. Determination of total analyte concentration
US9121859B2 (en) 2012-12-04 2015-09-01 Siemens Healthcare Diagnostics Inc. Compounds and methods for determination of FKBP-binding immunosuppressant drugs
EP2945942B1 (en) 2013-01-18 2018-05-09 ARK Diagnostics, Inc. Voriconazole immunoassays
EP2956444B1 (en) 2013-02-13 2018-05-30 ARK Diagnostics, Inc. Posaconazole immunoassays
CA2923140C (en) 2013-09-05 2023-09-26 Idexx Laboratories, Inc. Methods for detecting renal disease
WO2015067302A1 (en) 2013-11-05 2015-05-14 Ecole Polytechnique Federale De Lausanne (Epfl) Sensor molecules and uses thereof
WO2015094852A2 (en) 2013-12-17 2015-06-25 Siemens Healthcare Diagnostics Inc. Preparation of multi-hapten mutant g6pdh conjugates and their use for detection of multiple analytes
CN107003304A (zh) 2014-12-17 2017-08-01 西门子医疗保健诊断公司 用于羟考酮和羟吗啡酮的测定法的缀合物
EP3259593B1 (en) 2015-02-20 2022-10-05 IDEXX Laboratories, Inc. Homogenous immunoassay with compensation for background signal
EP3265074B1 (en) 2015-03-03 2020-08-12 ARK Diagnostics, Inc. Pregabalin immunoassays
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
MX2020003523A (es) 2017-10-19 2020-07-22 Idexx Lab Inc Deteccion de dimetilarginina simetrica.
CN110174363A (zh) * 2019-01-09 2019-08-27 北京九强生物技术股份有限公司 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途
US10745492B1 (en) 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
CN110078711B (zh) * 2019-04-19 2020-09-18 北京九强生物技术股份有限公司 一种卡马西平衍生物及其在免疫检测中的用途
CN110054620B (zh) * 2019-04-19 2021-01-26 北京九强生物技术股份有限公司 一种苯巴比妥衍生物及其在免疫检测中的用途
US20210048436A1 (en) 2019-08-15 2021-02-18 Psychemedics Corporation Homogeneous enzyme immunoassay for keratinized structures
US12517120B2 (en) 2020-01-07 2026-01-06 Beijing Strong Biotechnologies, Inc. Glucose-6-phosphate dehydrogenase mutant and use thereof in preparing detection reagent
EP4662205A1 (en) 2023-02-10 2025-12-17 Siemens Healthcare Diagnostics, Inc. Derivatives, immunogens, and antibodies and use of the same in detection of ecstasy-class compounds
WO2026030017A1 (en) * 2024-07-30 2026-02-05 Siemens Healthcare Diagnostics Inc. Nitazene analogs and conjugates and methods of production and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4233401A (en) 1977-07-14 1980-11-11 Syva Company Antienzyme homogeneous competitive binding assay
IT1199088B (it) * 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
US4622294A (en) * 1985-02-08 1986-11-11 Kung Viola T Liposome immunoassay reagent and method
DE3711881A1 (de) * 1987-04-08 1988-10-27 Merck Patent Gmbh Verfahren zur herstellung von glucosedehydrogenase aus bacillus megaterium
JPH0286779A (ja) * 1988-09-22 1990-03-27 Amano Pharmaceut Co Ltd 改良型組換えｄｎａ、それを含む形質転換体及びそれを用いた耐熱性グルコースデヒドロゲナーゼの製造法
DE4024158A1 (de) 1990-07-30 1992-02-06 Boehringer Mannheim Gmbh Klonierung und ueberexpression von glucose-6-phosphat-dehydrogenase aus leuconostoc dextranicus
JP2850515B2 (ja) * 1990-09-25 1999-01-27 東洋紡績株式会社 グルコースデヒドロゲナーゼおよびその製造法
US5244796A (en) 1990-10-12 1993-09-14 Syracuse University Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making glucose-6-phospate dehydrogenase
DE69132238T2 (de) 1990-11-20 2000-12-21 Dade Behring Marburg Gmbh Verfahren zur Stabilisierung von Enzym-Konjugaten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115616231A (zh) * 2019-07-04 2023-01-17 北京九强生物技术股份有限公司 酶标记物的制备方法

Also Published As

Publication number Publication date
DE69421617T2 (de) 2000-03-02
EP0710360B1 (en) 1999-11-10
WO1994024559A3 (en) 1995-01-26
ATE186598T1 (de) 1999-11-15
WO1994024559A2 (en) 1994-10-27
US6033890A (en) 2000-03-07
JP4223546B2 (ja) 2009-02-12
EP0710360A1 (en) 1996-05-08
JPH08510638A (ja) 1996-11-12
DE69421617D1 (de) 1999-12-16
US6455288B1 (en) 2002-09-24
US6090567A (en) 2000-07-18
CA2160115A1 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
ES2139087T3 (es) Inmunoensayos homogeneos que utilizan glucosa-6-fosfato-deshidrogenasas.
ES2064077T3 (es) Integracion estable de adn en genomas bacterianos.
ES2061929T5 (es) Nuevas enzimas proteoliticas y su utilizacion en detergentes.
AR005568A1 (es) Moleculas y construcciones de adn para aumentar la expresion de genes foraneos; celulas y plantas transformadas y metodo para producirlas
PT1526172E (pt) Processo para a replicação de vírus influenza em cultura celular e os vírus influenza que podem ser obtidos pelo processo
ES2084373T3 (es) Materiales y metodo para biosintesis de serina y productos afines a la serina.
DK1066060T3 (da) Mesenkymale stamceller som immunsuppresive midler
ATE346146T1 (de) Fibrinmikrokugeln und deren verwendungen
PL348629A1 (en) Alzheimer's disease secretase
SE8800238L (sv) Flytande enzymkompositioner
ATE223485T1 (de) Verfahren zur herstellung von rekombinant mhcii protein in mikroorganismen
DK1141335T3 (da) Kemisk modificerede enzymer med multipelt ladede varianter
IL180924A0 (en) Method for regulating cell proliferation and cell death
PT762901E (pt) Peptidos marcados com tecnecio-99m para imagiologia.
ATE417100T1 (de) Eine verbesserte immobilisierte penicillin g acylase
ATE246516T1 (de) Neue enzyme und prodrugs für adept
CZ77495A3 (en) Purified and isolated dna molecule, analog of beta-subunit of tryptophan synthase, prokaryotic or eukaryotic host cell, indole biosynthesis method and indigo biosythesis method
AU6266496A (en) Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
DK0889957T3 (da) Subtilisindimer med forbedret aktivitet og fremgangsmåde til fremstilling deraf
IL90414A (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
EP0972015A4 (en) ENZYMS WITH S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE-LIKE ACTIVITY.
DK264890A (da) Fremgangsmaade til biokemisk oxidation af steroider og genetisk konstruerede celler til denne anvendelse
PE20000759A1 (es) Gen de la citocroma oxidasa de hidroquinona del tipo bd
AR013853A1 (es) Un metodo para aumentar la expresion transgenica en una poblacion de celulas de monocotiledoneas y poblacion de celulas de monocotiledoneas conexpresion transgenica aumentada.
MX173840B (es) Procedimiento para producir una enzima de alfa-amilasa

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 710360

Country of ref document: ES